Wentworth CEO sees both capital and dividend growth opportunities in Tanzania's Mnazi gas field Watch Now

Less Ads, More Data, More Tools Register for FREE

IN BRIEF: Redx Pharma Plans USD30 Million Fundraise; Loss Narrows

Tue, 30th Jun 2020 14:47

Redx Pharma PLC - Macclesfield-based cancer treatment firm - Narrows pretax loss to GBP4.0 million in six months to March 31 from GBP4.1 million loss a year ago. Reports revenue of GBP1.2 million, versus none in first six months of prior year. Plans to raise USD30 million through issue of USD29 million convertible loan notes and a GBP812,000 share subscription from investment fund Sofinnova Crossover I SLP.

Current stock price: 22.50 pence

Year-to-date change: up more than double from 8.00p

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

Related Shares

More News

UK DIRECTOR DEALINGS SUMMARY: Braveheart Buys Stake In RMS From Brown

UK DIRECTOR DEALINGS SUMMARY: Braveheart Buys Stake In RMS From Brown

1 Jul 20 17:15

IN BRIEF: Redx Pharma Plans USD30 Million Fundraise; Loss Narrows

IN BRIEF: Redx Pharma Plans USD30 Million Fundraise; Loss Narrows

30 Jun 20 14:47

UK EXECUTIVE CHANGE SUMMARY: FastForward Innovations Names Chair, CEO

UK EXECUTIVE CHANGE SUMMARY: FastForward Innovations Names Chair, CEO

18 May 20 14:39

Redmile Acquires Additional 34% Stake In Redx As Offer Closes

Redmile Acquires Additional 34% Stake In Redx As Offer Closes

1 May 20 14:36

Login to your account

Don't have an account? Click here to register.